Reducing the risk of breast cancer.
Chlebowski
R T
RT
Harbor-UCLA Research and Education Institute, Torrance, Calif 90502, USA. rchlebow@whi.org
D016588:Anticarcinogenic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000517:prevention & control*; D004777:Environment; D004965:Estrogen Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008019:Life Style; D008408:Mastectomy; D010052:Ovariectomy; D020849:Raloxifene Hydrochloride / Q000009:adverse effects / Q000627:therapeutic use*; D012307:Risk Factors; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use*
D016588:Anticarcinogenic Agents; D004965:Estrogen Antagonists; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride